Development of brain metastases in non-small-cell lung cancer: high-risk features
Aim: Brain metastases (BM) are a common site of disease progression and treatment failure in non-small-cell lung cancer (NSCLC) and can be identified in up to 30–50% of patients. Although they are common, there is no standardized screening protocol for development of BM in NSCLC. Multiple clinical v...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | CNS Oncology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20450907.2024.2395804 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|